Clinical Studies Dr-D-Klein_PSSD-Experience-w-Chronic-wounds-2013 Efficacy-of-a-New-Multifunctional-Surfactant-based-Biomaterial-Dressing…,Zölß,Cech,IWJ140908
3/19/2014 · Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
The Bio-Physical Functions of PluroGel ® result in a moist, oxygenated, environment that facilitates wound healing 2. Research indicates that the PluroGel ® MGM may fill the breaks or “holes” created in damaged cell membranes which reduces or stops intracellular material leaking through the holes into the wound tissue 3, 4, 5, 12. This ...
9/8/2017 · PluroGel on Wounds of Mixed Etiology. ... A Pilot Study to Investigate the Efficacy of PluroGel in Healing Venous and Mixed Aetiology Leg Ulcers: ... To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
The strengths of this study include the large number of patients (> 1000), the prospective data collection, the real-world setting of a multicenter study, and the thorough follow-up. However, 2 limitations with this research should be noted.
Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law.
PluroGel® is a unique burn and wound dressing that is 100% water-soluble, bio-compatible, cell-friendly, and non-ionic; It aids in the creation of an optimal moist wound healing environment that helps to protect healthy tissue and soften wound debris
RESEARCH MONITOR Catherine R. Ratliff, PhD University of Virginia Box 81424 UVA Health System ... detail to conduct the clinical study as described. Furthermore, I agree to conduct the study as described ... and efficacy of topical PluroGel PN for up to 14 days in subjects with mildly infected diabetic foot ulcers
infuse PluroGel® PNN into the dressing without removing the dressing. The research team at ISR would not conduct Study #3 even though it had been paid for. CONCLUSION PluroGel® has been documented to be effective in eradicating bacterial contamination in a large animal model that replicates the injury and management of a traumatic war wound.
The purpose of this research was to find out if there is a link between burn ... A total of 15 people on 4 different teams were needed to conduct this study. They include the observer research team (n=3), simulation (SIM) research team (n=5), the IT support ... PluroGel® is a 100% water-soluble surfactant polymer paste that is
New Surfactant-based Dressing Product to Improve Wound Closure Rates of Nonhealing Wounds: A European Multicenter Study Including 1036 Patients
9/19/2014 · The primary translational research objective of the study is to demonstrate feasibility of using the Transcutaneous Raman Spectroscopy technology in a point-of-care environment. This study represents an initial evaluation of the device in a small cohort of human patients with diabetic foot ulcers.
The PluroGel® line of products offers simple solutions for complex wounds with a specialty in burn wound and chronic wound care. PluroGen Therapeutics, LLC. provides clinically advanced and advantaged burn, wound and skin care products. We work closely with doctors, nurses, patients and healthcare institutions to provide the best products for burn, wound and skin care to help people have a ...
5/22/2016 · The Institute for Wound Research at the University of Florida, Department of Obstetrics & Gynecology, University of Florida, Gainesville, FL, USA. Search for more papers by this author. Alessandra C Della Porta.
The study also reported that encapsulated Dox did not accumulate in the heart, which would alleviate the cardiotoxicity of Dox. Myhr et al. used Plurogel to encapsulate a chemotherapy drug (fluorouracil). The authors then applied ultrasound to mice inoculated with a human colon cancer cell line.
10/25/2018 · from research organizations. ... In the current study, Dr. Sharp enhanced the siRNAs' wound-healing potential by combining them with PluroGel -- a …
10/30/2018 · The CI and study sponsor, will comply with any safety reporting obligations for serious adverse device related events to the manufacturer, study sponsor, R&D Department(s) of the University Health Board(s) and the Ethics Committee, as defined in the applicable laws and regulations, and within the required timelines. Interventions. Device: PluroGel
5D Health Protection Group. 10.36. Contact
Albert Einstein College of Medicine company research & investing information. Find executives and the latest company news. ... In the current study, Dr. Sharp enhanced the siRNAs' wound-healing ...
10/25/2018 · In the current study, Dr. Sharp enhanced the siRNAs' wound-healing potential by combining them with PluroGel—a protective gel that keeps wounds moist and has antimicrobial properties when ...
The test agent was PluroGel®, a new water-soluble, biocompatible, topical gel, incorporating a unique triple antimicrobial combination of polymyxin B, nitrofurantoin, and nystatin (PluroGel® PNN). Zone of Inhibition Test (ZOI) The test used in this study was a modification of the standard Kirby-Bauer antibiotic